Literature DB >> 17395631

Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.

Igor Khaliulin1, Samantha J Clarke, Hua Lin, Joanna Parker, M-Saadeh Suleiman, Andrew P Halestrap.   

Abstract

We investigate whether temperature preconditioning (TP), induced by short-term hypothermic perfusion and rewarming, may protect hearts against ischaemic/reperfusion injury like ischaemic preconditioning (IP). Isolated rat hearts were perfused for 40 min, followed by 25 min global ischaemia and 60 min reperfusion (37 degrees C). During pre-ischaemia, IP hearts underwent three cycles of 2 min global ischaemia and 3 min reperfusion at 37 degrees C, whereas TP hearts received three cycles of 2 min hypothermic perfusion (26 degrees C) interspersed by 3 min normothermic perfusion. Other hearts received a single 6 min hypothermic perfusion (SHP) before ischaemia. Both IP and TP protocols increased levels of high energy phosphates in the pre-ischaemic heart. During reperfusion, TP improved haemodynamic recovery, decreased arrhythmias and reduced necrotic damage (lactate dehydrogenase release) more than IP or SHP. Measurements of tissue NAD+ levels and calcium-induced swelling of mitochondria isolated at 3 min reperfusion were consistent with greater inhibition of the mitochondrial permeability transition at reperfusion by TP than IP; this correlated with decreased protein carbonylation, a surrogate marker for oxidative stress. TP increased protein kinase Cepsilon (PKCepsilon) translocation to the particulate fraction and pretreatment with chelerythrine (PKC inhibitor) blocked the protective effect of TP. TP also increased phosphorylation of AMP-activated protein kinase (AMPK) after 5 min index ischaemia, but not before ischaemia. Compound C (AMPK inhibitor) partially blocked cardioprotection by TP, suggesting that both PKC and AMPK may mediate the effects of TP. The presence of N-(2-mercaptopropionyl) glycine during TP also abolished cardioprotection, indicating an involvement of free radicals in the signalling mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395631      PMCID: PMC1976396          DOI: 10.1113/jphysiol.2007.130369

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  70 in total

1.  Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation.

Authors:  R T Smolenski; D R Lachno; S J Ledingham; M H Yacoub
Journal:  J Chromatogr       Date:  1990-05-18

2.  Chelerythrine is a potent and specific inhibitor of protein kinase C.

Authors:  J M Herbert; J M Augereau; J Gleye; J P Maffrand
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

3.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

4.  Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart.

Authors:  Igor Khaliulin; Aviva Schneider; Esther Houminer; Joseph Bernard Borman; Herzl Schwalb
Journal:  Free Radic Biol Med       Date:  2004-10-01       Impact factor: 7.376

5.  Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat hearts.

Authors:  Hernando Leon; Laura L Atkinson; Jolanta Sawicka; Ken Strynadka; Gary D Lopaschuk; Richard Schulz
Journal:  Can J Physiol Pharmacol       Date:  2004-06       Impact factor: 2.273

6.  Preconditioning protects by inhibiting the mitochondrial permeability transition.

Authors:  Derek J Hausenloy; Derek M Yellon; Siva Mani-Babu; Michael R Duchen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-08       Impact factor: 4.733

7.  Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.

Authors:  M J Curtis; M J Walker
Journal:  Cardiovasc Res       Date:  1988-09       Impact factor: 10.787

8.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.

Authors:  Raymond R Russell; Ji Li; David L Coven; Marc Pypaert; Christoph Zechner; Monica Palmeri; Frank J Giordano; James Mu; Morris J Birnbaum; Lawrence H Young
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins.

Authors:  Igor Khaliulin; Herzl Schwalb; Ping Wang; Ester Houminer; Leonid Grinberg; Harvey Katzeff; Joseph B Borman; Saul R Powell
Journal:  Free Radic Biol Med       Date:  2004-07-01       Impact factor: 7.376

10.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

Authors:  M J Walker; M J Curtis; D J Hearse; R W Campbell; M J Janse; D M Yellon; S M Cobbe; S J Coker; J B Harness; D W Harron
Journal:  Cardiovasc Res       Date:  1988-07       Impact factor: 10.787

View more
  38 in total

1.  Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts.

Authors:  Daniel J Herr; Sverre E Aune; Donald R Menick
Journal:  J Vis Exp       Date:  2015-07-27       Impact factor: 1.355

2.  Temperature preconditioning: a cold-hearted answer to ischaemic reperfusion injury?

Authors:  Iffath A Ghouri; Ole J Kemi; Godfrey L Smith
Journal:  J Physiol       Date:  2007-10-25       Impact factor: 5.182

Review 3.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

4.  Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats.

Authors:  Nelson Escobales; Rebeca E Nuñez; Sehwan Jang; Rebecca Parodi-Rullan; Sylvette Ayala-Peña; Joshua R Sacher; Erin M Skoda; Peter Wipf; Walter Frontera; Sabzali Javadov
Journal:  J Mol Cell Cardiol       Date:  2014-10-23       Impact factor: 5.000

Review 5.  The small chill: mild hypothermia for cardioprotection?

Authors:  Renaud Tissier; Mourad Chenoune; Bijan Ghaleh; Michael V Cohen; James M Downey; Alain Berdeaux
Journal:  Cardiovasc Res       Date:  2010-07-08       Impact factor: 10.787

6.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

8.  Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice.

Authors:  Heeseog Kang; Benoit Viollet; Dianqing Wu
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

9.  Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Authors:  Samantha J Clarke; Igor Khaliulin; Manika Das; Joanne E Parker; Kate J Heesom; Andrew P Halestrap
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

Review 10.  Mitochondria and reperfusion injury of the heart--a holey death but not beyond salvation.

Authors:  Andrew P Halestrap
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.